1. Home
  2. ESYN vs CNSY Comparison

ESYN vs CNSY Comparison

Compare ESYN & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ESYN

EnerSyn Global Inc. Common Stock

N/A

Current Price

$1.80

Market Cap

19.8M

Sector

Health Care

ML Signal

N/A

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$1.74

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESYN
CNSY
Founded
2021
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.8M
20.6M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
ESYN
CNSY
Price
$1.80
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
14.6K
★ 166.6K
Earning Date
10-22-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
47.37
★ 87.61
EPS
★ N/A
N/A
Revenue
$866,926.00
★ $5,213,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$414.61
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.75
$1.49
52 Week High
$2.68
$4.03

Technical Indicators

Market Signals
Indicator
ESYN
CNSY
Relative Strength Index (RSI) 30.86 41.82
Support Level $1.82 $1.52
Resistance Level $2.13 $1.96
Average True Range (ATR) 0.15 0.18
MACD -0.02 0.04
Stochastic Oscillator 24.55 57.89

Price Performance

Historical Comparison
ESYN
CNSY

About ESYN EnerSyn Global Inc. Common Stock

EnerSyn Global Inc, formerly HWH International Inc and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore. The Company is presently developing Hapi Marketplace, a business-to-consumer platform featuring diverse product categories, and Hapi Wealth Builder, an educational program focused on wealth-building strategies.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: